Targeting mTOR With Everolimus and/or Physical Training for Preventing Postmenopausal Bone Loss and Accelerated Skeletal Aging: The RapaLoad Study
Latest Information Update: 30 Jan 2025
Price :
$35 *
At a glance
- Drugs Everolimus (Primary)
- Indications Osteoporosis
- Focus Therapeutic Use
- Acronyms RapaLoad
- 30 Jan 2025 New trial record